144 related articles for article (PubMed ID: 23534772)
1. Lack of any association between blood groups and lung cancer, independent of histology.
Oguz A; Unal D; Tasdemir A; Karahan S; Aykas F; Mutlu H; Cihan YB; Kanbay M
Asian Pac J Cancer Prev; 2013; 14(1):453-6. PubMed ID: 23534772
[TBL] [Abstract][Full Text] [Related]
2. Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey.
Urun Y; Utkan G; Cangir AK; Oksuzoglu OB; Ozdemir N; Oztuna DG; Kocaman G; Coşkun HŞ; Kaplan MA; Yuksel C; Demirkazik A; Icli F
Asian Pac J Cancer Prev; 2013; 14(5):2801-3. PubMed ID: 23803034
[TBL] [Abstract][Full Text] [Related]
3. ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non- small cell lung cancer.
Unal D; Eroglu C; Kurtul N; Oguz A; Tasdemir A; Kaplan B
Asian Pac J Cancer Prev; 2013; 14(6):3945-8. PubMed ID: 23886212
[TBL] [Abstract][Full Text] [Related]
4. Relationships between skin cancers and blood groups--link between non-melanomas and ABO/Rh factors.
Cihan YB; Baykan H; Kavuncuoglu E; Mutlu H; Kucukoglu MB; Ozyurt K; Oguz A
Asian Pac J Cancer Prev; 2013; 14(7):4199-203. PubMed ID: 23991976
[TBL] [Abstract][Full Text] [Related]
5. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
6. Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung.
Schulze AB; Schmidt LH; Baie L; Heitkötter B; Kuemmel A; Mohr M; Buhl R; Hillmann H; Geißler G; Kelsch R; Görlich D; Berdel WE; Hartmann W; Wiewrodt R
Clin Respir J; 2018 Mar; 12(3):1106-1117. PubMed ID: 28398662
[TBL] [Abstract][Full Text] [Related]
7. ABO and Rh blood groups and risk of colorectal adenocarcinoma.
Urun Y; Ozdemir NY; Utkan G; Akbulut H; Savas B; Oksuzoglu B; Oztuna DG; Dogan I; Yalcin B; Senler FC; Onur H; Demirkazik A; Zengin N; Icli F
Asian Pac J Cancer Prev; 2012; 13(12):6097-100. PubMed ID: 23464411
[TBL] [Abstract][Full Text] [Related]
8. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
Molina R; Augé JM; Bosch X; Escudero JM; Viñolas N; Marrades R; Ramírez J; Carcereny E; Filella X
Tumour Biol; 2009; 30(3):121-9. PubMed ID: 19506400
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer.
Slater G; Itzkowitz S; Azar S; Aufses AH
Dis Colon Rectum; 1993 Jan; 36(1):5-7. PubMed ID: 8416779
[TBL] [Abstract][Full Text] [Related]
11. Effects of ABO and FUT2 genetic transcription absence on ABH histo-blood group antigen expression in lung cancer patients.
Li J; Li S; Liu Q; Li Y; Zhou Q; Yuan S; Wang Z
Asian Pac J Cancer Prev; 2011; 12(12):3201-6. PubMed ID: 22471454
[TBL] [Abstract][Full Text] [Related]
12. Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology Group.
Ürün Y; Utkan G; Yalcin Ş; Coşkun HŞ; Koçer M; Özdemir NY; Kaplan MA; Arslan ÜY; Özdemir F; Öztuna D; Akbulut H; İçli F
Asian Pac J Cancer Prev; 2012; 13(8):4129-31. PubMed ID: 23098529
[TBL] [Abstract][Full Text] [Related]
13. The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.
Fukumoto K; Taniguchi T; Usami N; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
J Epidemiol; 2015; 25(2):110-6. PubMed ID: 25483106
[TBL] [Abstract][Full Text] [Related]
14. Influence of ABO blood group on susceptibility to different pathological types of lung cancer: a retrospective study.
Yang H; Zeng X; Zhang Y; Tong W; Yao G; Lan C; Liu J; Liu Z; Zhong N
World J Surg Oncol; 2022 Dec; 20(1):379. PubMed ID: 36464709
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group.
Tanriverdi O; Avci N; Oktay E; Kalemci S; Pilanci KN; Cokmert S; Menekse S; Kocar M; Sen CA; Akman T; Ordu C; Goksel G; Meydan N; Barutca S
Asian Pac J Cancer Prev; 2015; 16(14):5971-6. PubMed ID: 26320482
[TBL] [Abstract][Full Text] [Related]
16. Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.
Kargi A; Bisgin A; Yalcin AD; Kargi AB; Sahin E; Gumuslu S
Asian Pac J Cancer Prev; 2013; 14(8):4819-22. PubMed ID: 24083751
[TBL] [Abstract][Full Text] [Related]
17. ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases.
Halvorsen TB
Scand J Gastroenterol; 1986 Oct; 21(8):979-83. PubMed ID: 3095914
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
19. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.
Sánchez-Rodríguez P; Rodríguez MC; Sánchez-Yagüe J
Tumour Biol; 2015 Jul; 36(7):5687-98. PubMed ID: 25702090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
